An Update on the 10-year Results of JCOG 0802 | Professor Hisao Asamura

📌 Chapters 00:00 Introduction: Is Segmentectomy Really Affordable? 01:04 Extent of Resection and Prognosis: The Conventional View 01:58 SEER Database: Lobectomy vs Sublobar Resection 02:46 Lobectomy as the Present-Day Standard 03:17 JCOG 0802 Trial Design 04:43 Decision Policy: Overall Survival and Pulmonary Function 05:38 Postoperative Pulmonary Function (FEV1) 06:40 5-Year Overall Survival: 94.3% vs 91.1% 07:35 The 2020 Lancet Conclusion 08:00 Cause of Death at 5 Years 08:47 10-Year Overall Survival Results 09:25 What Changed Between 5 and 10 Years 10:40 Local Recurrence: 5.8% vs 11.2% 11:13 Cause of Death at 10 Years 12:22 Non-Malignant Deaths: Lobectomy vs Segmentectomy 13:19 Air Leak and Secondary Endpoints 14:35 10-Year Summary: Lobectomy Remains the Gold Standard 15:27 Looking Back: Was 5-Year OS the Right Endpoint? 16:31 Closing Question: Do You Still Do Segmentectomy? 16:56 Q&A Discussion 📌 About the Speaker Professor Hisao Asamura is Professor of Surgery and Chief of the Division of Thoracic Surgery at Keio University School of Medicine, and Principal Investigator of the JCOG 0802 trial. 🎓 About Virtual Grand Rounds Virtual Grand Rounds (VGR) is a free weekly medical education webinar series covering thoracic surgery, oncology, and respiratory medicine. Live sessions run every Friday at 8:00am UK time via Zoom and offer 1 CME credit to live attendees. Register for future sessions here: https://us02web.zoom.us/webinar/regis... 🔍 Topics Discussed Background and design of the JCOG 0802 trial Segmentectomy versus lobectomy in small peripheral lung cancer 10-year survival and long-term outcomes Implications for sublobar resection in clinical practice Future directions in surgical management of early-stage disease #ThoracicSurgery #LungCancer #Segmentectomy #JCOG0802 #CME #MedicalEducation